UgenTec secures USD9.3 million in Series A funding
UgenTec, a medical technology company that has developed an AI-driven polymerase chain reaction (PCR) analysis and workflow software, has closed a USD9.3 million (EUR7.5 million) funding round. UgenTec automates and standardises high-throughput molecular diagnostics, particularly PCR. PCR analysis is a widely-adopted method for analysing DNA. It has enabled molecular laboratories
